Pirfenidone Promising for RA-Linked Interstitial Lung Disease
TUESDAY, Oct. 4, 2022 (HealthDay News) — Pirfenidone may slow the rate of decline of forced vital capacity (FVC) among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), according to a study published online Sept. 5 in …
Learn MoreApremilast May Offer Cardiometabolic Benefit in Psoriasis Patients
TUESDAY, Oct. 4, 2022 (HealthDay News) — For patients with moderate-to-severe psoriasis, apremilast appears to have a neutral association with aortic vascular inflammation, generally beneficial associations with certain cardiometabolic biomarkers, an…
Learn MoreRituximab Studied as Add-On Therapy for New-Onset Myasthenia Gravis
TUESDAY, Oct. 4, 2022 (HealthDay News) — A single infusion of rituximab early after the onset of generalized myasthenia gravis improves outcomes at 16 weeks, according to a study published online Sept. 19 in JAMA Neurology.Fredrik Piehl, M.D., Ph.D.,…
Learn MoreMinority Patients Less Likely to Get Newer Alzheimer’s Meds
TUESDAY, Oct. 4, 2022 (HealthDay News) — While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cog…
Learn MoreResearch & Development Investments Do Not Explain Drug Price Variation
MONDAY, Oct. 3, 2022 (HealthDay News) — For a sample of 60 drugs, research and development investments do not explain the variation in list prices, according to a study published online Sept. 26 in JAMA Network Open.Olivier J. Wouters, Ph.D., from th…
Learn MoreCertain Meds Not Cost-Effective for First-Line Therapy of T2DM
MONDAY, Oct. 3, 2022 (HealthDay News) — Sodium-glucose cotransporter-2 (SGTL2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists are effective as first-line therapy for patients with type 2 diabetes, but are not cost-effective, accordin…
Learn MoreNifedipine ER Helps Control BP in Severe Preeclampsia
MONDAY, Oct. 3, 2022 (HealthDay News) — For individuals with preeclampsia with severe features, extended-release nifedipine reduces the receipt of intrapartum acute hypertensive therapy, according to a study published online Oct. 3 in Hypertension.Er…
Learn MoreAntisense Oligonucleotide Tofersen Reduces SOD1 in SOD1 ALS
MONDAY, Oct. 3, 2022 (HealthDay News) — The antisense oligonucleotide tofersen reduces the concentrations of superoxide dismutase 1 (SOD1) in patients with amyotrophic lateral sclerosis (ALS) associated with mutations in SOD1, but it does not improve…
Learn MoreGlucose-Lowering Meds Compared for Use With Metformin in T2DM
MONDAY, Oct. 3, 2022 (HealthDay News) — For patients with type 2 diabetes receiving metformin, the addition of glargine and liraglutide is more effective than glimepiride and sitagliptin for achieving and maintaining target glycated hemoglobin levels…
Learn MoreInterventions Can Improve Administration of VTE Prophylaxis
MONDAY, Oct. 3, 2022 (HealthDay News) — An electronic alert-triggered, patient-centered education bundle intervention or a nurse feedback intervention can improve administration of venous thromboembolism (VTE) prophylaxis, according to a study publis…
Learn More